HealtheRx Survey for Pulmonary Research Registry Recruitment - Trial NCT02653066
Access comprehensive clinical trial information for NCT02653066 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Chicago and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 41 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Chicago
Timeline & Enrollment
N/A
Dec 01, 2015
Dec 01, 2019
Primary Outcome
Cost per consented subject
Summary
The purpose of this research is to study the utility of using the HealtheRx as a tool to
 recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the
 University of Chicago. HealtheRx is an example of a potential recruitment tool that has high
 reach in populations typically underrepresented in research studies, uses a high tech
 infrastructure that allows matching of research opportunities to patient characteristics, but
 that delivers information in a low-tech, patient-centered mode using the printed HealtheRx
 prescription.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02653066
Non-Device Trial